The RSA Group strengthens commitment to Swiss life sciences
Posted on 11/04/2018
London, UK, 11th April 2018: The RSA Group, a leading Life Sciences executive search firm, is increasing its commitment to serving clients based in Switzerland. Thomas Schleimer, a Partner at The RSA Group with extensive international search and healthcare experience, will now also be working from the firm’s Basel office as the company expands its reach in the EMEA region.
Alex Bennett, CEO, commented: “The RSA Group has been operating in Switzerland for over 10 years and during that time, we’ve seen it become one of the world’s life science powerhouses. Our decision to dedicate Thomas’ focus to Switzerland reflects our confidence in the sector and in Thomas’ ability to work closely with life science business leaders in Switzerland in the challenging search for the world’s best talent.”
Thomas Schleimer, Partner, added: “I’m delighted to take on this wider role as it will further support our global platform and The RSA Group’s ability to work closer with a key Life Sciences market. Switzerland is home to a unique Life Sciences industry including MedTech, BioPharma, BioTechs, CdMOs and Diagnostics companies. Pharmaceutical giants like Novartis and Roche, continue to influence a thriving ecosystem of innovative players in MedTech, BioTech, and NanoTech. In an industry driven by innovation, senior executive level talent is often the difference between success and failure and I aim to use my 30-year experience working in executive search to help our Swiss clients attract and retain the most talented people. The three pillars for any organisation are; innovation, capital and people. The RSA Group can advise on the people strategy required to make the other pillars thrive.”